Clinical trial
A Randomised, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage After IVF With PGT-A Screened Euploid Embryo Transfer
NCT07724405 is registered in ClinicalTrials.gov with Fakih IVF Fertility Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage After IVF With PGT-A Screened Euploid Embryo Transfer
- Lead sponsor
- Fakih IVF Fertility Center
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 10, 2026
- Completion date
- October 10, 2027
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent miscarriages, recurrent pregnancy loss